SPONSOR
Grit Biotechnology
Total Trials
7
Recruiting
7
Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: Solid Tumor, AdultAuto Immune DiseaseHematological Malignancy (Leukemia- Lymphoma)AdultHNSCC
Grit Biotechnology is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Solid Tumor, Adult, Auto Immune Disease, Hematological Malignancy (Leukemia- Lymphoma), Adult.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Grit Biotechnology
How many clinical trials has Grit Biotechnology sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Grit Biotechnology, of which 7 are actively recruiting participants. These trials cover conditions including Solid Tumor, Adult, Auto Immune Disease, Hematological Malignancy (Leukemia- Lymphoma). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Grit Biotechnology research focus on?
Grit Biotechnology clinical trials span Solid Tumor, Adult, Auto Immune Disease, Hematological Malignancy (Leukemia- Lymphoma), Adult, HNSCC. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Grit Biotechnology clinical trial?
To participate in a Grit Biotechnology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Grit Biotechnology trials with current recruitment status updated daily.
Clinical Trials by Grit Biotechnology
NCT06397963
Recruiting
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
Solid Tumor, Adult
NCT07132112 EARLY_Phase 1
Recruiting
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease
Auto Immune Disease
NCT07131254 EARLY_Phase 1
Recruiting
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors
Hematological Malignancy (Leukemia- Lymphoma)
NCT06819280
Recruiting
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer
Adult
NCT06948981 Phase 1, Phase 2
Recruiting
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
Hematological Malignancy (Leukemia- Lymphoma)
NCT06190275
Recruiting
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
HNSCC
NCT06241781 Phase 2
Recruiting
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Adult
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology